Back

Black EquaLity in OCD NeuroGenomics (BELONG): Study Protocol

Williams, I. J.; Marquez, D. Y.; Lopez-lengowski, K. E.; Bommiasamy, M.; Onyeka, O. C.; Underwood, S. J.; Avery, J. E.; Gluckman, J.; Pichardo, T.; Chandler, R.; Brown, Y.; Mangen, K.; Choplin, E. G.; Black EquaLity in OCD NeuroGenomics (BELONG) Study Team, ; Richardson, S. C.; Buxbaum, J. D.; Storch, E. A.; Crowley, J. J.; Hankerson, S. H.; Grice, D. E.

2026-01-09 genetic and genomic medicine
10.64898/2026.01.08.26343678 medRxiv
Show abstract

Obsessive-compulsive disorder (OCD) is a chronic, serious psychiatric disorder that affects 2-3% of the population and is associated with high personal and societal costs. Genetic factors are estimated to explain roughly half the risk of developing OCD, and genomic studies are just beginning to identify common and rare genetic variants mediating this risk. A major goal of genomic studies is to yield insights into the etiology of OCD and identify molecular targets for the development of novel therapeutics. However, the overwhelming majority of subjects in existing genetic studies are of European ancestry, limiting the generalizability of these findings. To address this gap in understanding, we established the Black EquaLity in OCD NeuroGenomics (BELONG) study (https://belongocd.com/). BELONG aims to collect DNA and clinical data from 1,250 richly phenotyped OCD cases of African ancestry in a culturally sensitive manner. In addition, BELONG includes the collection of parental DNA samples for trio-based analyses and unrelated matched controls for case-control analysis. DNA samples will be sequenced using optimized approaches that will allow us to examine both rare and common genome-wide variation to identify OCD risk genes. We will also meta-analyze these data with other existing OCD genomic data. Overall, BELONG will increase the representation of Black Americans in OCD genetic research, which is necessary to generalize precision medicine discoveries in psychiatric genetics.

Published in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics (predicted rank #1) · training set

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · published here
22 papers in training set
Top 0.1%
18.5%
2
Translational Psychiatry
219 papers in training set
Top 0.3%
14.3%
3
American Journal of Psychiatry
20 papers in training set
Top 0.1%
10.1%
4
JAMA Psychiatry
13 papers in training set
Top 0.1%
6.3%
5
Molecular Psychiatry
242 papers in training set
Top 0.6%
4.8%
50% of probability mass above
6
European Neuropsychopharmacology
15 papers in training set
Top 0.1%
4.8%
7
Neuropsychopharmacology
134 papers in training set
Top 0.7%
4.3%
8
Biological Psychiatry
119 papers in training set
Top 0.9%
3.7%
9
PLOS ONE
4510 papers in training set
Top 48%
2.1%
10
Nature Human Behaviour
85 papers in training set
Top 2%
2.1%
11
Schizophrenia Bulletin
29 papers in training set
Top 0.4%
1.7%
12
Psychological Medicine
74 papers in training set
Top 1.0%
1.7%
13
Psychiatry Research
35 papers in training set
Top 1%
1.5%
14
Addiction Biology
47 papers in training set
Top 0.6%
1.2%
15
American Journal of Medical Genetics Part A
17 papers in training set
Top 0.2%
1.1%
16
Alcohol, Clinical and Experimental Research
12 papers in training set
Top 0.2%
1.1%
17
Frontiers in Psychiatry
83 papers in training set
Top 3%
0.9%
18
Nature Genetics
240 papers in training set
Top 6%
0.9%
19
Journal of Child Psychology and Psychiatry
25 papers in training set
Top 0.3%
0.9%
20
Psychiatry and Clinical Neurosciences
11 papers in training set
Top 0.3%
0.8%
21
JAMA Network Open
127 papers in training set
Top 5%
0.6%
22
Biological Psychiatry Global Open Science
54 papers in training set
Top 2%
0.6%
23
Genes, Brain and Behavior
29 papers in training set
Top 0.4%
0.6%